Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Anticholinergic syndrome
ADR ID BADD_A00266
ADR Hierarchy
17      Nervous system disorders
17.05      Neuromuscular disorders
17.05.01      Autonomic nervous system disorders
17.05.01.001      Anticholinergic syndrome
Description Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome. [MeSH]
MedDRA Code 10002757
MeSH ID D064807
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anticholinergic syndrome | Atropine-like syndrome | Syndrome anticholinergic | Syndrome atropine-like | Syndrome parasympatholytic | Anticholinergic Syndrome | Anticholinergic Syndromes | Syndrome, Anticholinergic | Syndromes, Anticholinergic | Peripheral Anticholinergic Syndrome | Anticholinergic Syndrome, Peripheral | Anticholinergic Syndromes, Peripheral | Peripheral Anticholinergic Syndromes | Syndrome, Peripheral Anticholinergic | Syndromes, Peripheral Anticholinergic | Central Anticholinergic Syndrome | Anticholinergic Syndrome, Central | Anticholinergic Syndromes, Central | Central Anticholinergic Syndromes | Syndrome, Central Anticholinergic | Syndromes, Central Anticholinergic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02346Venlafaxine0.000032%
BADD_D02432Glycopyrronium0.002837%
BADD_D02445Solifenacin0.000174%
The 2th Page    First    Pre   2    Total 2 Pages